|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.6700 USD | +1.53% |
|
+0.06% | +15.50% |
| Feb. 27 | VYNE Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Dec. 18 | RTW Biotech Opportunities announces new investment in Yarrow Bioscience | RE |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.53% | +0.06% | +7.23% | +17.54% | +15.50% | -48.85% | -90.73% | -98.85% | - | 22.33M | |
| +0.06% | +2.44% | -2.47% | -1.46% | -4.07% | +44.06% | +83.21% | +211.27% | +5,889.55% | 50.04B | |
| -1.28% | -0.07% | +3.04% | +6.88% | +20.17% | +81.96% | +64.48% | -15.13% | - | 48.62B | |
| +1.72% | -13.93% | -21.93% | -20.68% | -32.21% | +79.56% | +529.95% | +363.07% | +993.51% | 25.57B | |
| -1.53% | -3.18% | -4.62% | -12.88% | -3.12% | -2.40% | -12.36% | -48.99% | - | 23.32B | |
| -3.84% | -2.16% | -12.52% | -19.60% | +3.56% | +36.81% | -29.60% | -69.14% | - | 17.89B | |
| -1.66% | -4.83% | -6.21% | -11.58% | -16.92% | +32.60% | -41.30% | -24.52% | +66.90% | 16.2B | |
| -2.99% | -10.44% | -10.44% | +17.40% | +9.29% | +50.79% | +194.05% | +142.16% | - | 14.97B | |
| -0.84% | +5.27% | -6.19% | +25.60% | +7.43% | -23.65% | +992.44% | +246.04% | +126.39% | 14.58B | |
| -4.20% | -4.75% | -10.68% | +5.04% | +10.50% | +38.38% | - | - | - | 13.47B | |
| +3.70% | +5.32% | +14.08% | +16.78% | +17.02% | +38.81% | +167.41% | +101.53% | +814.26% | 12.89B | |
| +1.69% | -3.86% | -1.29% | +11.65% | -10.90% | +75.67% | +77.14% | +294.25% | - | 11.96B | |
| -1.47% | -1.59% | +22.09% | +22.03% | +17.31% | +409.69% | +98.07% | +14.73% | +1,389.10% | 10.97B | |
| -3.06% | -0.37% | +11.75% | +12.53% | +17.34% | +143.58% | +98.09% | +195.52% | +894.13% | 9.61B | |
| -2.76% | -11.38% | -17.02% | +11.39% | +24.93% | +117.53% | +124.59% | -3.12% | - | 8.65B | |
| -2.88% | -1.94% | -6.31% | -16.25% | -32.03% | - | - | - | - | 8.43B | |
| +0.37% | -2.74% | +11.64% | +37.09% | +311.62% | +224.70% | +257.46% | -43.64% | - | 8.54B | |
| +9.99% | +19.39% | +20.87% | +7.86% | +66.38% | +74.61% | +151.90% | +1,031.43% | +438.34% | 9.2B | |
| +0.74% | -.--% | -.--% | -.--% | -.--% | -.--% | +40.81% | +237.54% | - | 8.19B | |
| +2.61% | +0.92% | +1.48% | +4.36% | +4.60% | +47.33% | +167.06% | - | - | 8.31B | |
| Average | -0.21% | -0.92% | -0.38% | +5.69% | +21.32% | +74.80% | +159.59% | +149.07% | +1,326.52% | 16.07B | |
| Weighted average by Cap. | -0.51% | -1.67% | -2.29% | +2.18% | +11.70% | +68.94% | +161.03% | +137.23% | +2,424.38% |
- Stock Market
- Equities
- VYNE Stock
- Sector VYNE Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
